Position in NTRA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,423,234
+$602,726 QoQ
Shares Held
8,927
-1.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#346
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Narwhal Capital Management holds $5,252,342 across 2 Diagnostics & Research names. NTRA ranks #2 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
13,348 | $2,829,108 | |
| 2 | NTRA |
Natera, Inc.
This page
|
8,927 | $2,423,234 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,423,234 | 8,927 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,820,508 | 9,103 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,232,482 | 9,745 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,887,695 | 11,727 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,251,125 | 13,325 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,413,110 | 9,993 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,028,791 | 6,499 | Shares | Sole | 2025-01-22 | |
| No filing history on record for this holder in this stock. | ||||||